Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) EBIT (2009 - 2016)

Updated

Kazia Therapeutics' EBIT was -$14.55 million in FY2025 (year ended Jun 30, 2025).

Analysis

Kazia Therapeutics (KZIA) EBIT (2009 - 2016) Analysis & Trends

From FY2009 onward, Kazia Therapeutics has reported EBIT for 17 fiscal years.

  • Annual EBIT has moved between -$17.85 million (FY2024) and -$10.16 million (FY2021) over five years.
  • Per Business Quant data, EBIT in earlier fiscal years was -$17.85 million in FY2024, -$13.78 million in FY2023, -$17.64 million in FY2022 and -$10.16 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 6.18 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 6.27 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.39 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 3.46 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 5.47 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -9.12 Mn
Dec 31, 2015 -5.26 Mn
Dec 31, 2014 -6.47 Mn
Dec 31, 2013 -1.40 Mn
Aug 30, 2013 -5.22 Mn
Dec 31, 2012 -1.53 Mn
Dec 31, 2011 15.12 Mn
Dec 31, 2010 16.71 Mn
Dec 31, 2009 -223,602.22
API Access

Kazia Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=KZIA&period=max&api_key=YOUR_API_KEY